Shire Regenerative Medicine - 63011 Ballwin, MO

Business Name: Shire Regenerative Medicine
Categorized In: Health Services
Address: 12 Sweetwood Court, Ballwin, MO 63011
Phone Number: (636) 220-9031
NAICS Code: 6211110
SIC Code: 8099
Business Type: B2C (Business to Consumer)
Founding Year: 2013
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Continuum - Ballwin, MO 63011
Missouri Health Plans - Ballwin, MO 63011
Homebound Healthcare LLC - Ballwin, MO 63011
Physical Therapy Spine - Ballwin, MO 63011
Alternative Health Care - Ballwin, MO 63011
Foundations For Health LLC - Ballwin, MO 63011
Medical Placement Professionals LLC - Ballwin, MO 63011
Traditional Acupuncture - Ballwin, MO 63011
Health At Hand International - Ballwin, MO 63011
Health Career Agents Inc - Ballwin, MO 63011
Take Care Clinic - Ballwin, MO 63011
Westerfield Dena M DC - Ballwin, MO 63011
Mercy Clinic - Ballwin, MO 63011
Mmg West County Internal Medicine - Ballwin, MO 63011
Health Solutions Chiroprac - Ballwin, MO 63011
Kevin Kegin's American Warbird - Ballwin, MO 63011
Aegis Healthcare Strategies LLC - Ballwin, MO 63011
Benchmark Medical Billing - Ballwin, MO 63011
Atlas Institute of Health - Ballwin, MO 63011
Massage Envy Spa - Manchester - Ballwin, MO 63011

Shire Regenerative Medicine provides professional Health Services from its single location at the coordinates 38.607632,-90.528203.

The company offers B2C variables under the SIC code 8099 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 2013, the company can now be visited at 12 Sweetwood Court, Ballwin, Missouri 63011 or contacted through representative at (636) 220-9031.

For frequently asked questions and further inquiries about professional Health Services, get to know more about Shire Regenerative Medicine through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.